We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

111 hedge funds and large institutions have $408M invested in Enanta Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

71% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 28

13% more funds holding

Funds holding: 98 → 111 (+13)

3% less capital invested

Capital invested by funds: $419M → $408M (-$11.2M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

61% less call options, than puts

Call options by funds: $638K | Put options by funds: $1.62M

Holders
111
Holders Change
+13
Holders Change %
+13.27%
% of All Funds
3.22%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
24
Increased
48
Reduced
28
Closed
11
Calls
$638K
Puts
$1.62M
Net Calls
-$981K
Net Calls Change
-$1.16M

Top Buyers

1
Marshall Wace
Marshall Wace
United Kingdom
+$12.5M
2
SAM
Senzar Asset Management
New York
+$12.4M
3
GC
Guggenheim Capital
Illinois
+$7.68M
4
EAM
Eagle Asset Management
Florida
+$4.92M
5
NI
Numeric Investors
Massachusetts
+$4.43M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$51.4M
2
WSA
Wall Street Associates
California
-$2.4M
3
AAM
Aureus Asset Management
Massachusetts
-$2.39M
4
CCM
Cadence Capital Management
Massachusetts
-$2.38M
5
Allianz Asset Management
Allianz Asset Management
Germany
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
101
Creative Planning
Kansas
$34K +$34.1K +855 New
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$32.1K +$31K +777 +2,285%
SGAM
103
Smith Group Asset Management
Texas
$27K – – –
Royal Bank of Canada
104
Royal Bank of Canada
Ontario, Canada
$10K +$120 +3 +1%
LTFS
105
Ladenburg Thalmann Financial Services
Florida
$10K +$10.6K +265 New
Teacher Retirement System of Texas
106
Teacher Retirement System of Texas
Texas
$9K -$1.31K -33 -12%
BlackRock
107
BlackRock
New York
$9K – – –
Group One Trading
108
Group One Trading
Illinois
$6K +$3.99K +100 +161%
PTC
109
Private Trust Company
Ohio
$2K +$359 +9 +24%
KT
110
Kanaly Trust
Texas
$2K +$1.79K +45 New
Manulife (Manufacturers Life Insurance)
111
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$279 +$2.91K +73 +1%
AAM
112
Aureus Asset Management
Massachusetts
– -$2.39M -55,530 Closed
Thrivent Financial for Lutherans
113
Thrivent Financial for Lutherans
Minnesota
– -$1.32M -30,731 Closed
ProShare Advisors
114
ProShare Advisors
Maryland
– -$217K -5,036 Closed
ARC
115
Absolute Return Capital
Massachusetts
– -$169K -3,932 Closed
BRWM
116
B. Riley Wealth Management
Tennessee
– -$128K -2,987 Closed
VFA
117
Virtus Fund Advisers
Connecticut
– -$38K -882 Closed
OIA
118
Optimum Investment Advisors
Illinois
– -$30K -700 Closed
TRCT
119
Tower Research Capital (TRC)
New York
– -$17K -391 Closed
MFS
120
MSI Financial Services
Massachusetts
– -$11K -250 Closed
Bank of Montreal
121
Bank of Montreal
Ontario, Canada
– -$4K -90 Closed
U
122
UBS
Switzerland
– -$1.99K -50 Closed
1 2 3 4
5

ENTA Hedge Fund Activity: Q3 2014 in Review

111 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q3 2014, worth a combined $408M — down 2.7% from $419M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ENTA positions and 11 closed out — a net gain of 13 holders — while 48 added to existing stakes and 28 trimmed.

The largest buyer was Marshall Wace, adding an estimated $12.5M. The largest seller was RA Capital Management, cutting an estimated $51.4M.

  • 111 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q3 2014, up from 98 in Q2 2014.
  • Funds reported $408M of Enanta Pharmaceuticals stock for Q3 2014, down 2.7% quarter-over-quarter.
  • 24 funds opened new Enanta Pharmaceuticals positions in Q3 2014 and 11 closed out, a net change of +13 holders.
  • The largest Enanta Pharmaceuticals buyer in Q3 2014 was Marshall Wace, an estimated $12.5M added.
  • The largest Enanta Pharmaceuticals seller in Q3 2014 was RA Capital Management, an estimated $51.4M sold.

Based on aggregated 13F filings for Q3 2014.